Journal article icon

Journal article

Spatial transcriptomics reveals a key role of fibroblast-like vascular smooth muscle cells in human atherosclerotic cell crosstalk and stability

Abstract:
Background and Aims: Atherosclerotic plaques are the leading cause of cardiovascular events. Single-cell approaches have identified diverse human plaque cell phenotypes but their spatial distribution and interactions remain unclear. Here, intercellular communication patterns in human plaque microenvironments were mapped to reveal novel targets to prevent atherosclerotic events. Methods: Spatial transcriptomics (Visium, 10x) from 13 carotid plaques, and single-cell transcriptomics (cells = 51 981) were used to analyse cell phenotypes, cell trajectories, and intercellular communications. Cells contributing to plaque stability were explored using deconvolution of plaque bulk RNA-seq data (n = 78), histology, and survival analyses. Key cells and pathways were validated in apolipoprotein E (Apoe)−/− mice and in vitro. Genome-wide association study enrichment analyses were conducted using summary statistics of atherosclerotic diseases. LINCS L1000 data were used to explore drug repurposing. Results: A fibroblast-like vascular smooth muscle cell (VSMC) phenotype associated with extracellular matrix formation pathways (validated in Apoe−/− mice) emerged as a key regulator of intra-plaque ligand-receptor signalling, in particular in the cap region. A higher proportion of fibroblast-like VSMCs was found in asymptomatics, associated with stable plaque features and predicted a lower risk of future events. Genes specific to this VSMC phenotype were enriched in coronary artery disease and myocardial infarction. Finally, compounds, which could induce key marker genes were identified and validated in vitro. Conclusions: This study provides the first comprehensive spatial transcriptomics map of cell communication in human plaque microenvironments. A pivotal role of a fibroblast-like VSMC, orchestrating intraplaque cell signalling and contributing to plaque stability, was identified. Targeting these cells might present promising novel avenues for therapies.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1093/eurheartj/ehaf1091

Authors

More by this author
Role:
Author
ORCID:
0000-0002-2935-0181
More by this author
Role:
Author
ORCID:
0000-0002-9899-1345
More by this author
Role:
Author
ORCID:
0000-0002-3088-3153


More from this funder
Funder identifier:
10.13039/501100003793
Grant:
20220044
More from this funder
Funder identifier:
https://ror.org/044wr7g58
Grant:
Dnr IRC15-0067
More from this funder
Funder identifier:
https://ror.org/03zttf063
Grant:
2019-01260
More from this funder
Funder identifier:
https://ror.org/0433fd238
Grant:
CG-22-0254-H-02
More from this funder
Funder identifier:
https://ror.org/02pqxz266
Grant:
S-993166


Publisher:
Oxford University Press
Journal:
European Heart Journal More from this journal
Article number:
ehaf1091
Publication date:
2026-02-13
Acceptance date:
2025-12-18
DOI:
EISSN:
1522-9645
ISSN:
0195668X, 0195-668X


Language:
English
Keywords:
Source identifiers:
3756733
Deposit date:
2026-02-13
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP